Ainovis launches ANV-GEN Brain, its first foundational generative prototype that enables the generation of 3D brain MRIs using generative artificial intelligence, fully customisable images according to specific medical conditions and tonalities. Among the options available are diseases such as sclerosis, gliomas, dementia and healthy brains. In addition, classic MRI shades such as T1w, T1c, FLAIR, T2 and PD can be simulated.
The model has been trained with a large database of medical images and uses state-of-the-art computing, guaranteeing accuracy, realism and speed in the generated images, with an average of 3.50 seconds.
ANV-GEN Brain not only focuses on simulating specific medical conditions, but also on ensuring absolute anonymisation of the generated data. This facilitates the release of medical data to drive research and development of artificial intelligence in healthcare.
The generalisability of ANV-GEN Brain opens up new opportunities for the medical and scientific community, allowing AI models to be trained safely and efficiently without compromising patient privacy. This breakthrough represents a crucial step towards the ethical and responsible use of synthetic data in radiology and medicine of the future.